Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16).
Ann Oncol
; 31(4): 495-500, 2020 04.
Article
in En
| MEDLINE
| ID: mdl-32085891
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pleural Neoplasms
/
Mesothelioma, Malignant
/
Mesothelioma
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Ann Oncol
Year:
2020
Document type:
Article